Midas B Mulder

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Randomized Controlled Trial

Prognostic Factors

Top Venues

International journal of clinical pharmacy

British journal of clinical pharmacology

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Mirjam Simoons, Kishan A T Naipal, Huib de Jong, Caroline M den Hoed, Brenda C M de Winter, Midas B Mulder
Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series. Pharmacology research & perspectives 11 (3) (2023)
Midas B Mulder, B Doga, S D Borgsteede, A M van den Burg, H J Metselaar, C M den Hoed, N G M Hunfeld
Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study. International journal of clinical pharmacy 44 (5) (2022)
Midas B Mulder, Annemiek A van der Eijk, Corine H GeurtsvanKessel, Nicole S Erler, Brenda C M de Winter, Wojciech G Polak, Herold J Metselaar, Caroline M den Hoed
High antibody response in relation to immunosuppressive blood levels in liver transplant recipients after SARS-CoV-2 vaccination: an observational, cohort study. Gut 71 (12) (2022)
Midas B Mulder, Robert A de Man, Nassim Kamar, Gűlcan Durmaz, Joep de Bruijne, Thomas Vanwolleghem, Jacques Izopet, Peggy Gandia, Annemiek A van der Eijk, Teun van Gelder, Dennis A Hesselink, Brenda C M de Winter
Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection. Journal of viral hepatitis 28 (2) (2020)
Midas B Mulder, Erwin Birnie, Caroline van Dijck-van Boetzelaer, Gert-Jan van de Geijn, Egbert Boevé, Elsbeth M Westerman, Paul Hamberg
Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). Acta oncologica (Stockholm, Sweden) 60 (4) (2020)
Midas B Mulder, Hester L van den Hoek, Erwin Birnie, Antonie J P van Tilburg, Elsbeth M Westerman
Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer® ) versus ferric carboxy-maltose (Ferinject® ). A single center, cohort study. British journal of clinical pharmacology 85 (2) (2018)